中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2012年
5期
321-323
,共3页
胡章勇%杨军%夏绍碧%邓兰%王亚莉%范凌%石菡
鬍章勇%楊軍%夏紹碧%鄧蘭%王亞莉%範凌%石菡
호장용%양군%하소벽%산란%왕아리%범릉%석함
肝炎病毒,乙型%基因型%突变%聚合酶链反应%启动区(遗传学)
肝炎病毒,乙型%基因型%突變%聚閤酶鏈反應%啟動區(遺傳學)
간염병독,을형%기인형%돌변%취합매련반응%계동구(유전학)
Hepatitis B virus%Genotype%Mutations%Polymerase chain reactioin%Promoter regions (Genetics)
目的 探讨HBV(乙型肝炎病毒)C启动子区(CP) C1673T/C1799G联合变异的生物学和临床意义.方法 136名慢性HBV感染者,包括无症状携带者(ASC) 25例,慢性乙型肝炎(CHB)38例,慢性重型乙型肝炎(CSHB) 24例,乙肝肝硬化(LC) 36例,肝细胞肝癌(HCC)13例,用半巢氏PCR的方法结合直接测序法检测HBV基因亚型及CP区变异,分析C1673T/C1799G联合变异在不同基因亚型中的发生率及与HBV复制、e抗原表达和不同慢性HBV感染疾病谱的关系.结果 本组病例中,Ba亚型110例,Bj亚型1例,C1亚型7例,C2亚型8例,C1673T/C1799G联合变异发生率为80.9%,其中在Ba亚型中为96.4%,C1亚型为14.3%,C2亚型为12.5%,Ba亚型与C1和C2亚型比较,差异有统计学意义(P <0.0001).变异组HBV DNA载量与非变异组比较差异无统计学意义(P>0.05);e抗原阳性组变异率为71.4%,e抗原阴性组为87.5%,两组比较差异有统计学意义(P<0.05).从ASC、CHB、CSHB、LC到HCC组,变异的发生率差异无统计学意义(P>0.05).结论 C1673T/C17991G联合变异常见于Ba基因亚型,该变异不影响HBV DNA的复制水平,可能与不同慢性HBV感染疾病谱无关.
目的 探討HBV(乙型肝炎病毒)C啟動子區(CP) C1673T/C1799G聯閤變異的生物學和臨床意義.方法 136名慢性HBV感染者,包括無癥狀攜帶者(ASC) 25例,慢性乙型肝炎(CHB)38例,慢性重型乙型肝炎(CSHB) 24例,乙肝肝硬化(LC) 36例,肝細胞肝癌(HCC)13例,用半巢氏PCR的方法結閤直接測序法檢測HBV基因亞型及CP區變異,分析C1673T/C1799G聯閤變異在不同基因亞型中的髮生率及與HBV複製、e抗原錶達和不同慢性HBV感染疾病譜的關繫.結果 本組病例中,Ba亞型110例,Bj亞型1例,C1亞型7例,C2亞型8例,C1673T/C1799G聯閤變異髮生率為80.9%,其中在Ba亞型中為96.4%,C1亞型為14.3%,C2亞型為12.5%,Ba亞型與C1和C2亞型比較,差異有統計學意義(P <0.0001).變異組HBV DNA載量與非變異組比較差異無統計學意義(P>0.05);e抗原暘性組變異率為71.4%,e抗原陰性組為87.5%,兩組比較差異有統計學意義(P<0.05).從ASC、CHB、CSHB、LC到HCC組,變異的髮生率差異無統計學意義(P>0.05).結論 C1673T/C17991G聯閤變異常見于Ba基因亞型,該變異不影響HBV DNA的複製水平,可能與不同慢性HBV感染疾病譜無關.
목적 탐토HBV(을형간염병독)C계동자구(CP) C1673T/C1799G연합변이적생물학화림상의의.방법 136명만성HBV감염자,포괄무증상휴대자(ASC) 25례,만성을형간염(CHB)38례,만성중형을형간염(CSHB) 24례,을간간경화(LC) 36례,간세포간암(HCC)13례,용반소씨PCR적방법결합직접측서법검측HBV기인아형급CP구변이,분석C1673T/C1799G연합변이재불동기인아형중적발생솔급여HBV복제、e항원표체화불동만성HBV감염질병보적관계.결과 본조병례중,Ba아형110례,Bj아형1례,C1아형7례,C2아형8례,C1673T/C1799G연합변이발생솔위80.9%,기중재Ba아형중위96.4%,C1아형위14.3%,C2아형위12.5%,Ba아형여C1화C2아형비교,차이유통계학의의(P <0.0001).변이조HBV DNA재량여비변이조비교차이무통계학의의(P>0.05);e항원양성조변이솔위71.4%,e항원음성조위87.5%,량조비교차이유통계학의의(P<0.05).종ASC、CHB、CSHB、LC도HCC조,변이적발생솔차이무통계학의의(P>0.05).결론 C1673T/C17991G연합변이상견우Ba기인아형,해변이불영향HBV DNA적복제수평,가능여불동만성HBV감염질병보무관.
Objective To explore the biological and clinical significance of the double mutations of C1673T/C1799G in HBV C promoter (CP).Methods Totally 136 patients were enrolled,including 25 asymptomatic carriers (AsC),38 patients with chronic hepatitis B (CHB),24 patients with chronic severe hepatitis B (CSHB),36 cases with liver cirrhosis (LC) and 13 cases with hepatocellular carcinoma (HCC).HBV subgenotypes and mutations in CP of all samples were determined by nested-PCR and direct nucleotide sequence analysis.The C to T mutation at nucleotide 1673 and C to G at nucleotide 1799 were analyzed in different subgenotypes,and the relationships of C1673T/C1799G double mutations with HBV replication,the expression of HBeAg,and with the severity of liver disease after chronic HBV infection were studied.Results Of the 136 patients,110 were subgenotype Ba,1 was Bj,7 were C1,and 18 were C2.C1673T/C1799G double mutations in Ba were determined in 106 (96.4%) samples,which was significantly higher than in C1 (14.3%) and C2 (12.5%) subgenotype (P < 0.0001).In contrast to nonmutation group,HBV DNA content in mutation group had no significant difference (P > 0.05).The prevalence of the mutation was lower in HBeAg positive patients (71.4%) than in HBeAg negative patients (87.5 %) (P < 0.05).The frequencies of the double mutations were not significantly different among ASC,CHB,CSHB,LC and HCC groups (P > 0.05).Conclusion In Ba subgenotype,double mutations of C1673T/C1799G is much popular than in C1 and C2; the mutation has no effect on HBV replication,and may not be associated with the outcome of chronic HBV infection.